The research found that mice with Alzheimer's disease symptoms improved when a certain brain protein was suppressed.

Weizmann and Washington U. scientists harness CAR T-cell therapy to fight brain tissue inflammation in mice, potentially ...

Find out more about Alzheimer’s Research UK’s campaigning work and why your support is so crucial to helping us change the future of dementia treatment.

Scientists stress that the study represents an early signal, not a medical breakthrough. It identifies a potential avenue for ...

A simple brain training task performed for just over a month could reduce dementia risk by as much as a quarter, a ...

Campaigners have blasted the move as a "major disappointment”.

A protein that has long frustrated diabetes researchers is suddenly at the center of a very different fight. By targeting an enzyme called protein tyrosine phosphatase 1B, or PTP1B, scientists are ...

A new study suggests that a common respiratory bacterium may play an unexpected role in Alzheimer’s disease. Cedars-Sinai ...

Re:Cognition Health, a global leader in brain and memory health research, and Cera – Europe’s largest digital‑first home healthcare provider – have announced a new collaboration designed to expand ...

Chimeric antigen receptor (CAR) T cell therapy, a type of immunotherapy that leverages the immune system to combat diseases, is a powerful treatment option for certain cancers. The treatment relies on ...

Divergent diagnostic criteria is raising concerns that some patients are being misdiagnosed and unnecessarily treated.

For decades, Alzheimer’s disease has been framed as a one‑way slide, a slow erasure of memory that medicine could at best ...